Welcome to LookChem.com Sign In|Join Free
  • or
Benzenamine, N-(3-methyl-2-butenyl)-2-nitro- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

64085-42-3

Post Buying Request

64085-42-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

64085-42-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 64085-42-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,4,0,8 and 5 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 64085-42:
(7*6)+(6*4)+(5*0)+(4*8)+(3*5)+(2*4)+(1*2)=123
123 % 10 = 3
So 64085-42-3 is a valid CAS Registry Number.

64085-42-3Downstream Products

64085-42-3Relevant academic research and scientific papers

Microwave-assisted reductive cyclization of N-allyl 2-nitroanilines: A new approach to substituted 1,2,3,4-tetrahydroquinoxalines

Merisor, Elena,Conrad, Jürgen,Mika, Sabine,Beifuss, Uwe

, p. 2033 - 2036 (2007)

N-Allyl 2-nitrophenyl amines can be efficiently cyclized to yield alkenyl-1,2,3,4-tetrahydroquinoxalines in a single reaction step by means of a new microwave-assisted reductive domino process. Georg Thieme Verlag Stuttgart.

2, 4-DI-(NITROGEN CONTAINING GROUP) SUBSTITUTED PYRIMIDINE COMPOUND AND PREPARATION METHOD AND USE THEREOF

-

Paragraph 0122, (2018/07/29)

Provided are a 2, 4-di-(nitrogen containing group) substituted pyrimidine compound represented by a general formula (I), a pharmaceutically acceptable salt and a stereoisomer thereof, a preparation method thereof, and a use thereof in preparation of anti-tumor drugs. The compound having a structural feature shown in the general formula (I) can selectively suppress activity of mutant epidermal growth factor receptors (EGFR), including single-mutant EGFR (T790M) and double-mutant EGFR (including L858R/T790M and ex19del/T790M), and can suppress activity of single gain-of-function mutant EGFR (including L858R and ex19del) as well. The compound has a weak suppression effect on wild-type EFGR and a very high selectivity, and thus it has a potential to be used in preparation of drugs for treating EGFR mutant tumors, especially non-small cell lung cancer (NSCLC) comprising a T790M EGFR mutation.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 64085-42-3